These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 838841)

  • 1. The nature of the defect in a salt-wasting disorder in Jews of Iran.
    Rösler A; Rabinowitz D; Theodor R; Ramirez LC; Ulick S
    J Clin Endocrinol Metab; 1977 Feb; 44(2):279-91. PubMed ID: 838841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of salt-wasting disorders of adrenal and renal origin.
    Rösler A
    J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic responses to the administration of angiotensin II, K and ACTH in two salt-wasting syndromes.
    Rösler A; Theodor R; Boichis H; Gerty R; Ulick S; Alagem M; Tabachinik E; Cohen B; Rabinowitz D
    J Clin Endocrinol Metab; 1977 Feb; 44(2):292-301. PubMed ID: 190253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and nomenclature of the disorders of the terminal portion of the aldosterone biosynthetic pathway.
    Ulick S
    J Clin Endocrinol Metab; 1976 Jul; 43(1):92-6. PubMed ID: 947946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective hypoaldosteronism in Iranian Jews: An autosomal recessive trait.
    Cohen T; Theodor R; Rösler A
    Clin Genet; 1977 Jan; 11(1):25-30. PubMed ID: 830445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of steroids in urine for differentiation of pseudohypoaldosteronism and aldosterone biosynthetic defect.
    Honour JW; Dillon MJ; Shackleton CH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):325-31. PubMed ID: 7033278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital pseudohypoaldosteronism: case report and review. Effect of indomethacin during sodium chloride depletion.
    Rampini S; Furrer J; Keller HP; Bucher H; Zachmann M
    Helv Paediatr Acta; 1978 Jun; 33(2):153-67. PubMed ID: 659259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone.
    Ulick S; Wang JZ; Morton DH
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1415-20. PubMed ID: 1592889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for an aldosterone biosynthetic defect in congenital adrenal hyperplasia.
    Ulick S; Eberlein WR; Bliffeld AR; Chu MD; Bongiovanni AM
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1346-53. PubMed ID: 7440699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hypoaldosteronism caused by a probable anomaly of 18-hydroxylation].
    Jean R; Legrand JC; Meylan F; Rieu D; Astruc J
    Arch Fr Pediatr; 1969; 26(7):769-77. PubMed ID: 5355252
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Nimkarn S; Lin-Su K; Berglind N; Wilson RC; New MI
    J Clin Endocrinol Metab; 2007 Jan; 92(1):137-42. PubMed ID: 17032723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inborn error in the terminal step of aldosterone biosynthesis. Corticosterone methyl oxidase tpe II deficiency in a North American pedigree.
    Veldhuis JD; Kulin HE; Santen RJ; Wilson TE; Melby JC
    N Engl J Med; 1980 Jul; 303(3):117-21. PubMed ID: 6991942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big renin and biosynthetic defect of aldosterone in diabetes mellitus.
    deLeiva A; Christlieb AR; Melby JC; Graham CA; Day RP; Luetscher JA; Zager PG
    N Engl J Med; 1976 Sep; 295(12):639-43. PubMed ID: 184384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt wasting, raised plasma-renin activity, and normal or high plasma-aldosterone: a form of pseudohypoaldosteronism.
    Rösler A; Theodor R; Gazit E; Biochis H; Rabinowitz D
    Lancet; 1973 May; 1(7810):959-62. PubMed ID: 4121586
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective hypoaldosteronism with hyperreninemia in a diabetic patient.
    Morimoto S; Kim KS; Yamamoto I; Uchida K; Takeda R; Kornel L
    J Clin Endocrinol Metab; 1979 Nov; 49(5):742-7. PubMed ID: 489714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of adrenocorticotropin on desoxycorticosterone, corticosterone and aldosterone excretion.
    Biglieri EG; Shambelan M; Slaton PE
    J Clin Endocrinol Metab; 1969 Aug; 29(8):1090-101. PubMed ID: 4308415
    [No Abstract]   [Full Text] [Related]  

  • 17. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L; Mark AL; Kaloyanides GJ
    Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated aldosterone deficiency in man: acquired and inborn errors in the biosynthesis or action of aldosterone.
    Veldhuis JD; Melby JC
    Endocr Rev; 1981; 2(4):495-517. PubMed ID: 6273148
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical diagnosis and management of corticosterone methyl oxidase type II deficiency.
    Lee PD; Patterson BD; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1986 Jan; 62(1):225-9. PubMed ID: 3510001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.